Proficio Capital Partners LLC purchased a new position in shares of The Clorox Company (NYSE:CLX - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 55,707 shares of the company's stock, valued at approximately $9,047,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Brooklyn Investment Group increased its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new position in Clorox during the third quarter worth approximately $27,000. Continuum Advisory LLC lifted its stake in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock valued at $30,000 after buying an additional 138 shares during the last quarter. Asset Planning Inc purchased a new stake in Clorox in the fourth quarter valued at approximately $32,000. Finally, Halbert Hargrove Global Advisors LLC acquired a new stake in shares of Clorox in the fourth quarter valued at approximately $36,000. 78.53% of the stock is owned by hedge funds and other institutional investors.
Clorox Price Performance
Shares of CLX traded up $0.45 on Wednesday, reaching $145.33. The stock had a trading volume of 744,217 shares, compared to its average volume of 1,459,825. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The firm has a market capitalization of $17.90 billion, a PE ratio of 39.71, a PEG ratio of 2.62 and a beta of 0.45. The firm has a 50-day moving average of $153.71 and a 200 day moving average of $160.08. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.
Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the firm posted $2.16 earnings per share. Sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current year.
Clorox Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.36%. Clorox's dividend payout ratio (DPR) is 133.33%.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on CLX. DA Davidson lowered their price objective on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 5th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Barclays lifted their target price on Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a research note on Wednesday, February 5th. JPMorgan Chase & Co. increased their price target on Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a report on Tuesday, February 4th. Finally, StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $159.62.
View Our Latest Report on CLX
Clorox Company Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
